Limited Time Offer
Get $1000 towards your
first investment
Start investing in private markets with Linqto – your access to disruptive startups and pre-IPO companies.
*Terms and conditions apply. See details
Resilience, founded in 2016 and headquartered in San Francisco, California, is a leading cyber risk company that leverages artificial intelligence to enhance data migration and transfer risk management. The company's innovative ecosystem provides businesses with crucial information to identify cyber threats, implement rapid protection measures, and bolster cyber resiliency.
Since its inception, Resilience has successfully raised a total of $217 million in funding, demonstrating significant investor interest in its AI-driven cybersecurity solutions. The company's unique approach to accessing global data sources for pinpointing vulnerabilities and reducing risk has positioned it as a notable player in the rapidly evolving cybersecurity industry.
While there is currently no concrete information available regarding Resilience's IPO prospects, the company's substantial funding and focus on addressing critical cybersecurity challenges may attract attention from potential investors interested in the cybersecurity sector. However, it's important to note that any discussions about a potential Resilience IPO remain speculative at this time.
As with any private company, various factors could influence Resilience's decision to go public, including market conditions, the company's financial performance, and its long-term strategic goals. Investors interested in Resilience should continue to monitor official announcements from the company for any updates on its plans for the future.
Get $1000 towards your
first investment
*Terms and conditions apply. See details
While Resilience's IPO prospects remain uncertain, investors eager to gain exposure to innovative biopharmaceutical companies don't have to wait. At Linqto, we offer members access to interests in promising pre-IPO private companies, including potential leaders in the biotech and pharmaceutical sectors. Our platform allows you to diversify your portfolio with lower minimum investments, potentially benefiting from the growth of emerging industry pioneers like Resilience before they go public.
*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.
